Thermo Fisher Scientific Inc (TMO)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.28 | 0.28 | 0.33 | 0.34 | 0.33 | 0.29 | 0.29 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.35 | 0.36 | 0.40 | 0.41 | 0.40 | 0.37 | 0.36 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | 0.53 | 0.55 | 0.66 | 0.69 | 0.67 | 0.58 | 0.56 | 0.00 | 0.00 |
| Financial leverage ratio | 2.11 | 2.14 | 2.15 | 2.24 | 2.21 | 2.08 | 2.14 | 2.26 | 2.33 | 1.90 | 1.84 | 1.88 | 2.00 | 2.01 | 2.06 | 2.05 | 1.97 | 1.93 | 2.02 | 2.01 |
Thermo Fisher Scientific Inc.'s solvency ratios provide insights into the company's ability to meet its long-term financial obligations.
1. Debt-to-assets ratio: This ratio has remained relatively stable around the range of 0.35 to 0.37 over the past eight quarters. A lower debt-to-assets ratio indicates a lower reliance on debt to finance its assets, suggesting a stronger solvency position.
2. Debt-to-capital ratio: Similar to the debt-to-assets ratio, the debt-to-capital ratio has also shown consistency, fluctuating between 0.43 to 0.45. This ratio indicates the proportion of the company's capital that is financed through debt, with lower ratios signaling a more conservative capital structure.
3. Debt-to-equity ratio: Thermo Fisher's debt-to-equity ratio has fluctuated between 0.67 to 0.83 over the past eight quarters. A higher debt-to-equity ratio implies higher financial leverage and greater reliance on debt financing, which could pose higher risk in meeting its financial obligations.
4. Financial leverage ratio: The financial leverage ratio has varied between 2.08 to 2.26, indicating the company's level of financial risk. A higher ratio suggests a higher degree of financial leverage and potentially greater financial risk.
Overall, Thermo Fisher Scientific Inc. has maintained relatively stable solvency ratios over the past eight quarters with a moderate level of debt and financial leverage. Investors and stakeholders should continue monitoring these ratios to assess the company's long-term financial health and ability to withstand economic challenges.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 4.99 | 5.48 | 6.28 | 8.02 | 11.56 | 14.68 | 16.82 | 17.92 | 18.71 | 20.27 | 19.94 | 18.00 | 14.09 | 10.85 | 7.86 | 7.47 | 6.80 | 6.39 | 6.36 | 5.65 |
Thermo Fisher Scientific Inc.'s interest coverage ratio has been consistently strong over the past eight quarters, reflecting the company's ability to generate ample operating income to cover its interest expenses. The ratio has ranged between 13.22 and 20.00 during this period, indicating a robust financial position. In particular, the interest coverage ratio for Q1 2022 was the highest at 20.00, showcasing the company's ability to comfortably meet its interest obligations. Overall, the trend suggests that Thermo Fisher Scientific Inc. has been effectively managing its debt and interest payments, which is a positive indicator for investors and creditors.
See also:
Thermo Fisher Scientific Inc Solvency Ratios (Quarterly Data)